This lecture examines the broad PBS listing of immunotherapy for advanced/ metastatic cancer as a case study in innovative reimbursement decision-making. The session will cover the history and background of the decision, the approach taken to achieve it, and the outcomes that followed. It will then consider the implications for future reimbursement policy — exploring whether this represents an isolated exception or a model that can be built upon.

The lecture will be of interest to those working in market access, health economics, clinical development, and health policy.

Moderated by Oona Reardon (Director, Pulse Economics), the event includes a presentation with Greg Cook (Senior Director for Access, Policy & Advocacy, BMS), followed by an audience Q&A.

We hope you can join this event. Register early to receive the webinar details.

Contact the host of Immunotherapy broad PBS listing case study: Unicorn or a Way Forward

There were 0 errors found in the information you submitted: